These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 26890211)
21. Medications and monitoring in nontuberculous mycobacteria infections. Egelund EF; Fennelly KP; Peloquin CA Clin Chest Med; 2015 Mar; 36(1):55-66. PubMed ID: 25676519 [TBL] [Abstract][Full Text] [Related]
22. A review of current and promising nontuberculous mycobacteria antibiotics. Cantelli CR; Dassonville-Klimpt A; Sonnet P Future Med Chem; 2021 Aug; 13(16):1367-1395. PubMed ID: 34165325 [TBL] [Abstract][Full Text] [Related]
23. The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea. Kim SY; Kim CK; Bae IK; Jeong SH; Yim JJ; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Kang YA Diagn Microbiol Infect Dis; 2015 Feb; 81(2):107-11. PubMed ID: 25467784 [TBL] [Abstract][Full Text] [Related]
24. Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series. Namkoong H; Morimoto K; Nishimura T; Tanaka H; Sugiura H; Yamada Y; Kurosaki A; Asakura T; Suzuki S; Fujiwara H; Yagi K; Ishii M; Tasaka S; Betsuyaku T; Hoshino Y; Kurashima A; Hasegawa N BMC Infect Dis; 2016 Aug; 16():396. PubMed ID: 27506679 [TBL] [Abstract][Full Text] [Related]
25. Nontuberculous mycobacteria in respiratory infections: advances in diagnosis and identification. Somoskovi A; Salfinger M Clin Lab Med; 2014 Jun; 34(2):271-95. PubMed ID: 24856528 [TBL] [Abstract][Full Text] [Related]
26. The therapeutic approach to non-tuberculous mycobacterial infection of the lung. McGrath EE; Anderson PB Pulm Pharmacol Ther; 2010 Oct; 23(5):389-96. PubMed ID: 20542128 [TBL] [Abstract][Full Text] [Related]
27. Species Identification and Clarithromycin Susceptibility Testing of 278 Clinical Nontuberculosis Mycobacteria Isolates. Nie W; Duan H; Huang H; Lu Y; Chu N Biomed Res Int; 2015; 2015():506598. PubMed ID: 26146620 [TBL] [Abstract][Full Text] [Related]
28. Cefoxitin continuous infusion for lung infection caused by the Mycobacterium abscessus group. Czaja CA; Levin A; Moridani M; Krank JL; Curran-Everett D; Anderson PL Antimicrob Agents Chemother; 2014 Jun; 58(6):3570-1. PubMed ID: 24733469 [No Abstract] [Full Text] [Related]
29. Advances in the management of pulmonary disease due to Mycobacterium abscessus complex. Koh WJ; Stout JE; Yew WW Int J Tuberc Lung Dis; 2014 Oct; 18(10):1141-8. PubMed ID: 25216826 [TBL] [Abstract][Full Text] [Related]
37. Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: clinical features and susceptibilities of the isolates. Lee MR; Ko JC; Liang SK; Lee SW; Yen DH; Hsueh PR Int J Antimicrob Agents; 2014 May; 43(5):438-41. PubMed ID: 24718088 [TBL] [Abstract][Full Text] [Related]
38. Clinical significance of respiratory isolates for Mycobacterium abscessus complex from pediatric patients. Do PC; Nussbaum E; Moua J; Chin T; Randhawa I Pediatr Pulmonol; 2013 May; 48(5):470-80. PubMed ID: 22833551 [TBL] [Abstract][Full Text] [Related]
39. Mycobacterium shimoidei, a Rare Pulmonary Pathogen, Queensland, Australia. Baird TM; Carter R; Eather G; Thomson R Emerg Infect Dis; 2017 Nov; 23(11):1919-1922. PubMed ID: 29048290 [TBL] [Abstract][Full Text] [Related]
40. The effect of alcohol consumption in the treatment of nontuberculous mycobacteria. Jacob M; Silva R; Gaio R; Duarte R Pulmonology; 2020; 26(4):249-252. PubMed ID: 31672591 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]